Incannex Healthcare Inc ADR (IXHL) Stock Price, Quote & News

Company Profile

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety diso...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 61 4 0984 0786

Website: www.incannex.com

Address:

8 Century Circuit, Suite 105 Norwest, Sydney, Australia

malibu_rum67 Jul. 4 at 8:28 PM

$IXHL … Happy Independence Day 🇺🇸 BULLS 🐂 !!!

0 · Reply

stockro1 Jul. 4 at 2:28 PM

$IXHL The market has a habit of mispricing companies when the story changes faster than the valuation. I think that’s happening here. • Targeting one of the world’s largest unmet medical markets (Obstructive Sleep Apnoea) • Positive Phase 2 efficacy • Strong balance sheet, minimal debt • Multiple catalysts ahead • Small share count • Valuation that still looks modest if development succeeds This is now an execution story. Today’s valuation appears to price in far more failure than success. Watching for: ✔️ First patient dosed ✔️ Clinical progress ✔️ Institutional buying ✔️ Strategic partnerships The biggest gains often come before consensus catches up. Do your own research. $IXHL $VKTX $ALT $HIMS $LLY

4 · Reply

RogueFF7 Jul. 4 at 1:46 PM

$IXHL if you haven’t seen this…it’s pretty funny. Happy 4th. The battle continues Monday. https://x.com/DschlopesIsBack/status/2073179433729445921/video/1?s=46

1 · Reply

JuggernautRaider Jul. 4 at 1:12 PM

$SLS @FUD_Slayer i love fighting acute myeloid leukemia as much as the next guy but, one of my Golden Rules of Thumb that my Irish friend @AkBearHunter knows: if you have made a 900% return (10 X), why are you still holding? Go for 1000% (11x) or 1900% (19x) ? Love the spunk but $ALT $IXHL and $TNXP could all 5x, 10x, or 20x the next year (boom! 💥) Or, they could go bust faster than the Titantic 🛳️ Welcome to biopharma. Ask my guy @Night_Owl_Biotech . He is wicked smart too 😉 @alphaonetrading has been quiet lately 🤫 I should be too.

3 · Reply

JackB2025 Jul. 4 at 6:08 AM

$IXHL shares- 12m or so post split and financing. Share buy back has been active. What’s peoples thoughts on shares on offer now? If we were back to 10m and got bought out for $1BN that’s $100/share. IMO it’ll be valued higher. Thoughts?

2 · Reply

Michaelthoaicaonguyen Jul. 4 at 5:13 AM

$IXHL $NTLA $ABAT $SLNH 🇺🇸 Happy 250th Birthday Heavenly Father, today we thank You for 250 years of freedom, hope, and opportunity. We are grateful for every generation that sacrificed, served, and prayed so we could enjoy the blessings of this nation. Lord, we know America is not perfect, and neither are we. We have stumbled, made mistakes, and fallen short, yet through Your grace You have never stopped loving us or giving us the opportunity to grow. Help us learn from our past, seek what is right, and become a nation that reflects justice, compassion, humility, and love. Bless our leaders with wisdom, protect our military, veterans, and first responders, and watch over every family across this land. Heal our divisions, strengthen our faith, and remind us that true freedom is a gift from You. As we celebrate this historic milestone, may we never take our freedoms for granted. May Your hand continue to guide America, and may we always strive to be a people who honor You in all.

3 · Reply

noclowns Jul. 4 at 2:54 AM

$IXHL source?

1 · Reply

RogueFF7 Jul. 4 at 1:11 AM

$IXHL DReaMzz will be completed between November 2026 and May 2027. There will be catalysts along the way. Depending on the success of the Top Line Data we could be looking at 25-42 per share before moving into phase 3. No doubt we are seeing momentum coming our way. Because of the buyback program the OS could be under 8.5M shares. Incredible.

0 · Reply

stockro1 Jul. 3 at 9:50 PM

$IXHL big

0 · Reply

topstockalerts Jul. 3 at 5:35 PM

$IXHL keep an eye on it for next week

0 · Reply

Incannex granted IHL-42X composition patent by USPTO

Jun 25, 2026, 8:00 AM EDT - 9 days ago

Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea

2026-06-10T12:06:25.000Z - 24 days ago

Incannex receives A$6.04M tax incentive refund

Jun 10, 2026, 8:00 AM EDT - 24 days ago

Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility

Jun 9, 2026, 8:00 AM EDT - 25 days ago

Incannex Announces Initiation of Research Coverage by Alliance Global Partners

2026-06-08T11:05:32.000Z - 26 days ago

Incannex initiated with a Buy at Alliance Global

May 15, 2026, 7:00 AM EDT - 7 weeks ago

Incannex Healthcare Quarterly report: Q3 2026

2026-05-14T19:10:49.000Z - 7 weeks ago

Incannex commences DReaMzz clinical study of IHL-42X in OSA

May 14, 2026, 10:35 AM EDT - 7 weeks ago

Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea

May 12, 2026, 8:00 AM EDT - 7 weeks ago

Incannex Healthcare Wins MedTech Breakthrough Award for IHL-42X, Underscoring Leadership in Next-Generation Drug Development

May 7, 2026, 10:00 AM EDT - 2 months ago

Incannex Healthcare Recognized for Innovative Drug Development Solutions by MedTech Breakthrough

Apr 22, 2026, 8:00 AM EDT - 2 months ago

Incannex Healthcare PSX-001 Program Aligns with White House Executive Order Accelerating Access to Psychedelic Treatments for Serious Mental Illness

2026-03-27T12:12:54.000Z - 3 months ago

Incannex reactivates share repurchase program

Mar 27, 2026, 8:00 AM EDT - 3 months ago

Incannex Reactivates Share Repurchase Program, Underscoring Confidence in Valuation and Strategic Position

2026-03-25T12:11:47.000Z - 3 months ago

Incannex enters partnership agreement with American Academy of Sleep Medicine

Mar 25, 2026, 8:00 AM EDT - 3 months ago

Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research

2026-03-18T12:27:15.000Z - 3 months ago

Incannex reports balance sheet with $75M in cash, no debt

Mar 18, 2026, 8:00 AM EDT - 3 months ago

Incannex Highlights Strong Balance Sheet with Approximately $75 Million in Cash and No Debt as Company Advances IHL-42X Development

2026-03-17T12:16:04.000Z - 3 months ago

Incannex regains compliance with Nasdaq minimum bid price rule

Mar 17, 2026, 8:00 AM EDT - 3 months ago

Incannex Regains Compliance with Nasdaq Minimum Bid Price Requirement

2026-03-12T12:27:43.000Z - 4 months ago

Incannex prices 2M shares at $5.00 in registered direct offering

2026-03-12T12:21:15.000Z - 4 months ago

Incannex announces enhanced development strategy for IHL-42X

Mar 12, 2026, 8:05 AM EDT - 4 months ago

Incannex Healthcare Inc. Announces Pricing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

2026-02-27T00:50:18.000Z - 4 months ago

Incannex Healthcare Inc trading halted, news pending

2026-02-25T14:29:04.000Z - 4 months ago

Incannex board approves 1-for-30 reverse stock split

Feb 25, 2026, 9:20 AM EST - 4 months ago

Incannex Announces Reverse Stock Split

Feb 20, 2026, 6:00 AM EST - 4 months ago

Incannex Healthcare Slides: Investor presentation

Feb 18, 2026, 6:35 PM EST - 4 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2026

Feb 13, 2026, 7:00 AM EST - 5 months ago

Incannex Healthcare Quarterly report: Q2 2026

2026-01-29T13:16:52.000Z - 5 months ago

Incannex announces additional appointments to Clinical Advisory Board

Jan 29, 2026, 8:00 AM EST - 5 months ago

Incannex Healthcare Announces Additional Appointments to Clinical Advisory Board

2026-01-22T13:21:38.000Z - 5 months ago

Incannex announces formation of clinical advisory board for PSX-001 program

Jan 22, 2026, 8:00 AM EST - 5 months ago

Incannex Healthcare Announces Formation of Clinical Advisory Board for PSX-001 Program

Jan 15, 2026, 8:00 AM EST - 6 months ago

Incannex Healthcare Wins Research and Development Award for Obstructive Sleep Apnea Program in the 2025 Clinical Trials Arena Excellence Awards

Jan 14, 2026, 8:00 AM EST - 6 months ago

Incannex Healthcare Delivers Transformational 2025 Progress and Outlines Well-Funded Outlook for 2026

Dec 18, 2025, 7:00 AM EST - 7 months ago

Incannex Healthcare Proxy statement: Proxy Filing

Dec 16, 2025, 7:00 AM EST - 7 months ago

Incannex Healthcare Proxy statement: Proxy Filing

Dec 3, 2025, 8:00 AM EST - 7 months ago

Incannex Granted FDA Fast Track Designation for IHL-42X in Obstructive Sleep Apnea (OSA)

Nov 20, 2025, 9:34 AM EST - 8 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2026

Nov 14, 2025, 4:00 PM EST - 8 months ago

Incannex Healthcare Quarterly report: Q1 2026

Oct 30, 2025, 8:00 AM EDT - 8 months ago

Incannex Provides Shareholder Update Highlighting Clinical Progress, Capital Discipline, and EOY 2025 Strategic Focus

Oct 27, 2025, 8:00 AM EDT - 8 months ago

Incannex Healthcare Proxy statement: Proxy Filing

Oct 27, 2025, 8:00 AM EDT - 8 months ago

Incannex Healthcare Proxy statement: Proxy Filing

Oct 22, 2025, 8:00 AM EDT - 9 months ago

Incannex Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

Sep 29, 2025, 9:30 AM EDT - 9 months ago

Incannex Healthcare Annual report: Q4 2025

Aug 26, 2025, 8:00 AM EDT - 11 months ago

Incannex Reports Positive Results from Phase 2 Clinical Trial of PSX-001 (Psi-GAD) for Generalised Anxiety Disorder

Aug 22, 2025, 8:00 AM EDT - 11 months ago

Incannex Healthcare Authorizes $20 Million Share Repurchase Program

Aug 19, 2025, 4:29 PM EDT - 11 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update

Aug 8, 2025, 8:00 AM EDT - 11 months ago

Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea

Jul 31, 2025, 8:00 AM EDT - 1 year ago

Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilise ATM in Near Term

Jul 30, 2025, 8:00 AM EDT - 1 year ago

Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X

Jul 25, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo

Jun 24, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch

Jun 18, 2025, 7:30 AM EDT - 1 year ago

Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X

Jun 17, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy

Jun 12, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

Jun 3, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program

May 29, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance

May 28, 2025, 4:21 PM EDT - 1 year ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025

May 28, 2025, 7:00 AM EDT - 1 year ago

Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results

May 20, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution

May 16, 2025, 9:00 AM EDT - 1 year ago

Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants

May 16, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Proxy statement: Proxy Filing

May 15, 2025, 9:30 AM EDT - 1 year ago

Incannex Healthcare Earnings release: Q3 2025

May 15, 2025, 9:30 AM EDT - 1 year ago

Incannex Healthcare Quarterly report: Q3 2025

May 15, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates

May 14, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Proxy statement: Proxy Filing

Apr 16, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Registration statement: Registration Filing

Apr 3, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Registration statement: Registration Filing

Mar 18, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Proxy statement: Proxy Filing

Mar 7, 2025, 2:10 PM EST - 1 year ago

Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules

Feb 18, 2025, 5:51 PM EST - 1 year ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025

Feb 14, 2025, 7:30 AM EST - 1 year ago

Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates

Feb 14, 2025, 7:00 AM EST - 1 year ago

Incannex Healthcare Earnings release: Q2 2025

Feb 14, 2025, 7:00 AM EST - 1 year ago

Incannex Healthcare Quarterly report: Q2 2025

Feb 4, 2025, 9:15 AM EST - 1 year ago

Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board

Jan 23, 2025, 7:30 AM EST - 1 year ago

Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea

Dec 2, 2024, 4:48 PM EST - 1 year ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025

Nov 26, 2024, 7:00 AM EST - 1 year ago

Incannex Healthcare Registration statement: Registration Filing

Nov 14, 2024, 4:05 PM EST - 1 year ago

Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates

Nov 14, 2024, 7:00 AM EST - 1 year ago

Incannex Healthcare Earnings release: Q1 2025

Nov 14, 2024, 7:00 AM EST - 1 year ago

Incannex Healthcare Quarterly report: Q1 2025

Nov 12, 2024, 7:00 AM EST - 1 year ago

Incannex Healthcare Proxy statement: Proxy Filing

Nov 6, 2024, 7:00 AM EST - 1 year ago

Incannex Healthcare Registration statement: Registration Filing

Nov 6, 2024, 7:00 AM EST - 1 year ago

Incannex Healthcare Registration statement: Registration Filing

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Incannex Healthcare Proxy statement: Proxy Filing

Oct 24, 2024, 7:30 AM EDT - 1 year ago

Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer

malibu_rum67 Jul. 4 at 8:28 PM

$IXHL … Happy Independence Day 🇺🇸 BULLS 🐂 !!!

0 · Reply

stockro1 Jul. 4 at 2:28 PM

4 · Reply

RogueFF7 Jul. 4 at 1:46 PM

$IXHL if you haven’t seen this…it’s pretty funny. Happy 4th. The battle continues Monday. https://x.com/DschlopesIsBack/status/2073179433729445921/video/1?s=46

1 · Reply

JuggernautRaider Jul. 4 at 1:12 PM

3 · Reply

JackB2025 Jul. 4 at 6:08 AM

2 · Reply

Michaelthoaicaonguyen Jul. 4 at 5:13 AM

3 · Reply

noclowns Jul. 4 at 2:54 AM

$IXHL source?

1 · Reply

RogueFF7 Jul. 4 at 1:11 AM

0 · Reply

stockro1 Jul. 3 at 9:50 PM

$IXHL big

0 · Reply

topstockalerts Jul. 3 at 5:35 PM

$IXHL keep an eye on it for next week

0 · Reply

Anonymouspapertrader Jul. 3 at 4:42 PM

$IXHL 25B? No no no, WAY OFF........Yes, the U.S. Treasury has been issuing massive, record-breaking volumes of short-term debt, culminating in a colossal $117 billion single-day surge in public debt on June 30, 2026. This aggressive issuance pushes total public debt to an unprecedented $39.46 trillion.This relentless wave of T-bill supply acts as a giant vacuum cleaner for liquidity, pulling cash directly out of money market funds and driving the Fed’s Overnight Reverse Repo (ON RRP) facility down to nearly zero

0 · Reply

Blueviking Jul. 3 at 4:16 PM

$NWBO $ABUS $IXHL https://youtu.be/-4j2_M-4omQ?is=QLs7ZYpvmTLwPc7z

0 · Reply

malibu_rum67 Jul. 3 at 6:14 AM

$IXHL … It’s so Fun 🤩 Seeing Old Faces 🥰!!! BELIEVE 💚💚💚

0 · Reply

malibu_rum67 Jul. 3 at 6:12 AM

$IXHL … Let The Fire 🔥 Works Begin Next Week🔥🔥🔥!!!

0 · Reply

OtCjimmy Jul. 3 at 3:48 AM

$IXHL you get to $4 Monday after these few days of green and I'll be in for more than a flip. Maybe there's some truth to the idiot Joel getting his shares and suddenly giving a damn 💩🗑️

1 · Reply

StrawberryRips Jul. 3 at 2:03 AM

$IXHL strong forward outlook, strong pipeline. Under $4 is a gift. I can see that upward $8 gap closing. Float is small.

1 · Reply

Greyghost013 Jul. 3 at 1:32 AM

$IXHL I need to put a million down on poly market for this to never hold $4

0 · Reply

seams Jul. 3 at 1:12 AM

$IXHL

0 · Reply

Michaelthoaicaonguyen Jul. 3 at 12:49 AM

$IXHL been busy all day I just have a chance to look at her and

0 · Reply

topstockalerts Jul. 2 at 11:14 PM

$IXHL this one is making a pretty compelling case

2 · Reply

SIWCG Jul. 2 at 11:02 PM

$IXHL Let’s get back to $35

1 · Reply

Santa_Claus_Trades Jul. 2 at 10:41 PM

$IXHL Looking better and better every day. Everyone have a wonderful Fourth of July weekend! Please be safe, drink responsibly, share time with friends and loved ones, and try to help someone else less fortunate than you. I'll see you all on Monday morning! 🎅

4 · Reply

Market Cap	47.50M
Revenue (ttm)	90,000.00
Net Income (ttm)	-46.89M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	4.12
Profit Margin	-52,100.00%
Debt to Equity Ratio	0.00

Volume	491,000
Avg Vol	317,158
Day's Range	N/A - N/A
Shares Out	11.97M
Stochastic %K	94%
Beta	6.95
Analysts	Hold
Price Target	$18.00